Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

AstraZeneca presents new PROTACs for cancer

April 27, 2022

Cullgen identifies new PROTACs

April 27, 2022

Scorpion Therapeutics describes new EGFR and/or HER2 inhibitors

April 27, 2022

ARTS-021 shows promising antitumor activity in CCNE1-amplified cancer models

April 27, 2022

PAK4 inhibition enhances anti-PD-1 therapy in prostate cancer

April 26, 2022

Targeting CD166 overcomes platinum resistance in ovarian cancer

April 26, 2022

AI Therapeutics acquires EntreChem's EC-8042 for pediatric cancers

April 26, 2022

Jiangsu Chia Tai Tianqing Pharmaceutical researchers synthesize new AKT inhibitors

April 26, 2022

BeiGene patents new MAP4K1 inhibitors

April 26, 2022

Discovery of novel oridonin analogues as potent anticancer agents

April 26, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...